1-1 of 1
Susan Lerner, MS, RHIA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR), an Active Regimen for Heavily Treated Patients with CLL.

William G. Wierda, MD, PhD, Susan O’Brien, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Farhad Ravandi-Kashani, MD, Jorge Cortes, MD, Francis Giles, MD, Michael Andreeff, MD, PhD, Charles Asa Koller, MD, Susan Lerner, MS, RHIA, Hagop M. Kantarjian, MD, Michael J. Keating, MBBS
Journal: Blood
Blood (2006) 108 (11): 31.
https://doi.org/10.1182/blood.V108.11.31.31
Published: 2006